Implementation and Impact of Multidisciplinary Medication Review in Surgery Departments on Medication Management of Elderly Patients

简要总结

主要结局

次要结局

• Description of reason for non-transmission of multidisciplinary correspondence documents in the B2 group(Hospital discharge (maximum 30 days))
• Proportion of proposed medication modifications made by the collaborative team accepted and/or made permanent(3 months after hospital discharge)
• Time required for Multidisciplinary Medication Review in the interventional groups (B1 and B2)(Hospital discharge (maximum 30 days))
• Time required for ransmitting multidisciplinary correspondence documents in B2 group(Hospital discharge (maximum 30 days))
• Rate of patients for whom a follow-up review of proposed medication changes has been performed by the pharmacist in the B2 group(2 months post discharge)
• Mortality rate in each group(3 months after hospital discharge)
• Description of mode of diffusion of multidisciplinary correspondence documents in the B2 group(Hospital discharge (maximum 30 days))
• Rate of patients with at least one rehospitalization in each group(3 months after hospital discharge)
• patient satisfaction in all groups (A, B1, B2)(3 months after hospital discharge)
• Proportion of proposed medication modifications made by the clinical pharmacist accepted by the clinical doctor during the Multidisciplinary Medication Review in the experimental groups(Hospital discharge (maximum 30 days))
• Number of potentially inappropriate medications per patient in each group(3 months after hospital discharge)
• Number of multidisciplinary correspondence documents sent to the community acotors in B2 group(Hospital discharge (maximum 30 days))
• Number of multidisciplinary correspondence documents transmitted by community pharmacist in group B2(2 months post hospital discharge)
• Healthcare team satisfaction in interventional groups (B1, B2)(3 months after hospital discharge)